Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2443-2451

  Xie, Minqiang ^a   Zhang, H ^a   Xu, Y ^a   Liu, T ^a   Chen, S ^a   Wang, J ^a   Zhang, T ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cisplatin; Folate receptor; Laryngeal carcinoma; Molecular targeting; Nanomedicine; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; FOLATE RECEPTOR; FOLIC ACID; IRON;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCYTOSIS; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NANOMEDICINE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION;

EID: 84880112745     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s46327     Document Type: Article

References (30)

1. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem. 2005;338(2): 284-293.
2. Elnakat H, Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev. 2004;56(8):1067-1084.
3. Salazar MD, Ratnam M. The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev. 2007;26(1):141-152.
4. Hartmann LC, Keeney GL, Lingle WL, etal. Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer. 2007;121(5):938-942.
5. Dainty LA, Risinger JI, Morrison C, etal. Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma. Gynecol Oncol. 2007;105(3):563-570.
6. Kalli KR, Oberg AL, Keeney GL, etal. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol. 2008;108(3): 619-626.
7. Leamon CP, Reddy JA. Folate-targeted chemotherapy. Adv Drug Deliv Rev. 2004;56(8):1127-1141.
8. Fani M, Tamma ML, Nicolas GP, etal. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates. Mol Pharm. 2012;9(5):1136-1145.
9. Al Jammaz I, Al-Otaibi B, Amer S, Al-Hokbany N, Okarvi S. Novel synthesis and preclinical evaluation of folic acid derivatives labeled with (18)F-[FDG] for PET imaging of folate receptor-positive tumors. Nucl Med Biol. 2012;39(6):864-870.
10. Al Jammaz I, Al-Otaibi B, Amer S, Okarvi SM. Rapid synthesis and in vitro and in vivo evaluation of folic acid derivatives labeled with fluorine-18 for PET imaging of folate receptor-positive tumors. Nucl Med Biol. 2011;38(7):1019-1028.
11. Liang B, He ML, Xiao ZP, etal. Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery. Biochem Biophys Res Commun. 2008;367(4):874-880.
12. Duarte S, Faneca H, Lima MC. Folate-associated lipoplexes mediate efficient gene delivery and potent antitumoral activity in vitro and in vivo. Int J Pharm. 2012;423(2):365-377.
13. Saba NF, Wang X, Müller S, etal. Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head Neck. 2009;31(4):475-481.
14. Wang X, Li J, Wang Y, etal. HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano. 2009;3(10):3165-3174.
15. Dosio F, Arpicco S, Stella B, Brusa P, Cattel L. Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. Int J Pharm. 2009;382(1-2):117-123.
16. Hong G, Yuan R, Liang B, Shen J, Yang X, Shuai X. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drug. Biomed Microdevices. 2008;10(5):693-700.
17. Ward BB, Dunham T, Majoros IJ, Baker JR Jr. Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma. J Oral Maxillofac Surg. 2011;69(9):2452-2459.
18. Xie M, Xu Y, Liu J, Zhang T, Zhang H. Preparation and characterization of folate targeting magnetic nanomedicine loaded with cisplatin. J Nanomater. 2012;2012:921034.
19. Zhang Q, Zhang Y, Yang Y, Xiang G. Specific binding of folate conjugated PGA to FR-positive tumor cells. Chinese Pharmacological Bulletin. 2007;23(6):746-750.
20. Razak AR, Siu LL, Le Tourneau C. Molecular targeted therapies in all histologies of head and neck cancers: an update. Curr Opin Oncol. 2010;22(3):212-220.
21. Goerner M, Seiwert TY, Sudhoff H. Molecular targeted therapies in head and neck cancer. Head Neck Oncol. 2010;2:8.
22. Iwakiri S, Sonobe M, Nagai S, Hirata T, Wada H, Miyahara R. Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers. Ann Surg Oncol. 2008;15(3): 889-899.
23. Allard JE, Risinger JI, Morrison C, etal. Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas. Gynecol Oncol. 2007;107(1):52-57.
24. Kim DK, Zhang Y, Voit WK, Raob V, Muhammeda M. Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles. J Magn Mater. 2001;225(1-2):30-36.
25. Xu XQ, Shen H, Xu JR, Xie MQ, Li XJ. The colloidal stability and core-shell structure of magnetite nanoparticles coated with alginate. Appl Surf Sci. 2006;253(4):2158-2164.
26. Xie M, Chen S, Xu X, Li Z, Shen H, Xie J. Preparation of two kinds of superparamagnetic carriers-supported cis-platinum-complexes and the comparison of their characteristics. Chin Sci Bull. 2006;51(2):151-157.
27. Chen S, Xie M, Wang L, Long Z, Li Z, Zhang H. Safety assessment of modified cisplatinum magnetic nanomedicine. China Pharmacy. 2008;19(25):1941-1943.
28. Xie M, Wang L, Chen S, Xu X, Shen H. Tissue distribution of cisplatin-loaded magnetic nanomedicine in mice. Chinese Pharmaceutical Journal. 2010;45(21):1644-1647.
29. Huang S, Xie M, Li Y, Yuan X, Chen S. An experimental study of the distribution and targeting effect of CDDP-loaded magnetic nanoparticles in nude mice with transplanted nasopharyngeal carcinoma. J Med Res. 2011;40(2):22-26.
30. Long Z, Xie M, Zhang T, Shen H, Xu X, Guo L. Effect of targeted therapy with cisplatin-loaded magnetic nanoparticles combined with radiotherapy for nasopharyngeal carcinoma in nude mice. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29(9):1827-1830. Chinese.